Seeking Alpha · BEAM · October 27, 2026

Beam Therapeutics Inc. (BEAM) Reviews Initial Phase I II BEAM-301 Data in Glycogen Storage Disease Type 1a Transcript

Get the app for more

Explore stock news, insights and company research.